Disclosure from Vaping Professionals Wanted: Exciting Rewards Await!

Industry Insight by 2FIRSTS
Jan.16.2024
Disclosure from Vaping Professionals Wanted: Exciting Rewards Await!
Rewards ranging from CN¥200 to CN¥1000 for adopted releases of information. Looking forward to your participation!

To obtain first-hand industry information, 2FIRSTS is thrilled to announce the launch of a rewarding tip-off initiative starting from January 16th. We have established a dedicated mailbox to encourage professionals within the industry to share exclusive leads in exchange for attractive rewards.

 

The information you provide can include, but is not limited to, industry dynamics, market insights, unforeseen events, company developments, and more. As long as your tip meets our requirements, 2FIRSTS will promptly assign editors to follow up, ensuring that the information receives timely attention.

 

Upon verification and adoption of the tip, the informant stands a chance to receive cash rewards ranging from ¥200 to ¥1000 (amounts may vary). In case of duplicate tips, only the first informant will be eligible for the reward.

 

Terms and Conditions:

 

Time Frame: 

Effective from January 16, 2023, ongoing.

 

Reward Mechanism: 

Cash rewards ranging from ¥200 to ¥1000 for adopted tips (only the first informant will be rewarded in case of duplicate tips).

 

Tip-off Content: 

Inclusive of, but not limited to, industry dynamics, market information, unforeseen events, company movements within the electronic cigarette industry.

 

Participation Method: 

If you are a professional in the e-cigarette industry, simply send the crucial information you possess to our dedicated email address [info@2firsts.com]. We will promptly follow up on your tip.

 

Through this interactive platform, we look forward to establishing closer connections with industry professionals and collectively driving the development of the vaping industry. We appreciate everyone's continuous support for 2FIRSTS and eagerly await your active participation in creating more enriching and accurate industry content!

 

2FIRSTS Editorial Department

 


About 2FIRSTS

 

Established in early 2022, 2FIRSTS is a globally influential aerosol technology media and think tank. Our core readership includes regulatory authorities from various countries, international new tobacco companies, distributors, supply chain enterprises, non-profit organizations, and media outlets. 2FIRSTS brings readers the latest global information, forward-thinking topics, in-depth analyses, insights, and rich data and information. We are committed to promoting high-quality development of the global new tobacco industry through media and research, contributing to harm reduction initiatives worldwide.

 

2FIRSTS has currently established platforms such as 2firsts.cn (Chinese), 2firsts.com (International), and 2firsts.com/es (Spanish), with a daily visitation exceeding 10,000.

 

With offices in Shenzhen, Hong Kong, New York, Europe, and collaborations with international new tobacco companies, regulatory authorities, and media outlets, 2FIRSTS maintains excellent cooperation and close communication. We are also proud partners and official media representatives for major global new tobacco exhibitions.

On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
German prosecutors and customs authorities are conducting a criminal investigation into an alleged cross-border organised vape network. Authorities say that between January 2024 and March 2025, four employees of an unnamed Chinese e-cigarette manufacturer allegedly built a network of sales agents and wholesalers that brought more than 7.6 million nicotine disposable vapes into Germany, causing an estimated €33.3 million in excise-tax losses. The manufacturer has not been named. Some products visible in enforcement images have packaging resembling products from FUMOT’s portfolio. European regulatory records from 2024, FUMOT’s public overseas-sales materials and records involving German vape importer and distribution company Zamu-Pro GmbH also show FUMOT/RandM products and German distribution activity during the period covered by the investigation.
Sep.21
Product | BAT Revises Japan's VELO Convenience Store Lineup, Adding ¥380 Mango Pouches as Selected SKUs Exit
Product | BAT Revises Japan's VELO Convenience Store Lineup, Adding ¥380 Mango Pouches as Selected SKUs Exit
British American Tobacco's Japanese subsidiary, BAT Japan, launched VELO Mango Ice Medium on November 2, 2026, with distribution expanding to selected 7-Eleven, FamilyMart, NewDays and Seicomart stores from November 3. The new oral tobacco product contains 15 pouches per can and retails for ¥380, featuring a mango and cooling flavor profile at Medium intensity. At the same time, BAT Japan raised prices on multiple existing VELO products from ¥360 to ¥380 per can and withdrew selected SKUs from convenience store distribution without discontinuing them entirely. The changes affect product assortment, pricing and retail channel allocation.
product
Nov.04
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
EU Commission Clarifies Vaping, Smokeless Nicotine Use in Proposed Cardiovascular Checks
The European Commission has clarified to 2Firsts that its proposed cardiovascular health checks would assess smoking, vaping and the use of smokeless nicotine products as part of patients’ medical histories. The Commission also said Member States may organise additional checks within their healthcare systems. In the same response, it pointed to JRC research on e-cigarettes, heated tobacco products and nicotine pouches that has fed into the evaluation of EU tobacco legislation.
Nov.09